Dow Down 1.00% Nasdaq Down 0.97%

Amarin Corporation plc (AMRN)

-NasdaqGM
1.07 Down 0.02(1.83%) 12:00PM EDT - Nasdaq Real Time Price
Prev Close:1.09
Open:1.08
Bid:1.06 x 17200
Ask:1.07 x 13300
1y Target Est:2.27
Beta:0.68
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:1.05 - 1.10
52wk Range:1.05 - 7.39
Volume:1,085,312
Avg Vol (3m):2,760,190
Market Cap:184.99M
P/E (ttm):N/A
EPS (ttm):-0.62
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for AMRN

Comparison

Symbol% ChgMkt Cap
AMRNDown 1.83%184.99M
MRKDown 0.67%169.85B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):4.48
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.54
Quarterly EPS Est (Sep-14) :-0.13
Mean Recommendation*:2.8
PEG Ratio (5 yr expected):-0.03

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization therapeutic products for the treatment for cardiovascular diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback